327 related articles for article (PubMed ID: 29894414)
1. Risk Factors and Clinical Course for Liver Steatosis or Nonalcoholic Steatohepatitis After Living Donor Liver Transplantation.
Miyaaki H; Miuma S; Taura N; Shibata H; Sasaki R; Soyama A; Hidaka M; Takatsuki M; Eguchi S; Nakao K
Transplantation; 2019 Jan; 103(1):109-112. PubMed ID: 29894414
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and risk factors of steatosis after liver transplantation and patient outcomes.
Hejlova I; Honsova E; Sticova E; Lanska V; Hucl T; Spicak J; Jirsa M; Trunecka P
Liver Transpl; 2016 May; 22(5):644-55. PubMed ID: 26707008
[TBL] [Abstract][Full Text] [Related]
3. Recipient But Not Donor Adiponectin Polymorphisms Are Associated With Early Posttransplant Hepatic Steatosis in Patients Transplanted for Non-Nonalcoholic Fatty Liver Disease Indications.
John BV; Aiken T; Garber A; Thomas D; Lopez R; Patil D; Konjeti VR; Fung JJ; McCollough AJ; Askar M
Exp Clin Transplant; 2018 Aug; 16(4):439-445. PubMed ID: 29863454
[TBL] [Abstract][Full Text] [Related]
4. Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation.
Kim H; Lee K; Lee KW; Yi NJ; Lee HW; Hong G; Choi Y; You T; Suh SW; Jang JJ; Suh KS
Clin Transplant; 2014 May; 28(5):521-9. PubMed ID: 24579874
[TBL] [Abstract][Full Text] [Related]
5. Most Cases of Cryptogenic Cirrhosis May Be Nonobese Nonalcoholic Steatohepatitis - Risk Factors of Liver Steatosis After Liver Transplantation for Cryptogenic Cirrhosis: A Retrospective Study.
Fukushima M; Miyaaki H; Sasaki R; Haraguchi M; Miuma S; Hara T; Soyama A; Hidaka M; Eguchi S; Nakao K
Intern Med; 2023 May; 62(10):1415-1423. PubMed ID: 36171128
[TBL] [Abstract][Full Text] [Related]
6. Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation.
Shaked O; Demetris J; Levitsky J; Feng S; Loza BL; Punch J; Reyes J; Klintmalm G; Jackson W; DesMarais M; Sayre P; Shaked A; Reddy KR
Transplantation; 2022 Jan; 106(1):106-116. PubMed ID: 33982909
[TBL] [Abstract][Full Text] [Related]
7. Allograft steatohepatitis in progressive familial intrahepatic cholestasis type 1 after living donor liver transplantation.
Miyagawa-Hayashino A; Egawa H; Yorifuji T; Hasegawa M; Haga H; Tsuruyama T; Wen MC; Sumazaki R; Manabe T; Uemoto S
Liver Transpl; 2009 Jun; 15(6):610-8. PubMed ID: 19479804
[TBL] [Abstract][Full Text] [Related]
8. Non-alcoholic fatty liver disease in liver transplant recipients: another story of "seed and soil".
Dumortier J; Giostra E; Belbouab S; Morard I; Guillaud O; Spahr L; Boillot O; Rubbia-Brandt L; Scoazec JY; Hadengue A
Am J Gastroenterol; 2010 Mar; 105(3):613-20. PubMed ID: 20040915
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic steatohepatitis recurrence and rate of fibrosis progression following liver transplantation.
Sourianarayanane A; Arikapudi S; McCullough AJ; Humar A
Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):481-487. PubMed ID: 28253211
[TBL] [Abstract][Full Text] [Related]
10. Frequency of Cardiovascular Events and Effect on Survival in Liver Transplant Recipients for Cirrhosis Due to Alcoholic or Nonalcoholic Steatohepatitis.
Piazza NA; Singal AK
Exp Clin Transplant; 2016 Feb; 14(1):79-85. PubMed ID: 26581602
[TBL] [Abstract][Full Text] [Related]
11. Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis.
Galvin Z; Rajakumar R; Chen E; Adeyi O; Selzner M; Grant D; Sapisochin G; Greig P; Cattral M; McGilvray I; Ghanekar A; Selzner N; Lilly L; Patel K; Bhat M
Liver Transpl; 2019 Jan; 25(1):56-67. PubMed ID: 30609189
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of fatty liver disease after liver transplantation and risk factors for recipients and donors.
Horiuchi K; Kogiso T; Sagawa T; Taniai M; Kotera Y; Egawa H; Tokushige K
Ann Hepatol; 2022; 27(2):100670. PubMed ID: 35051631
[TBL] [Abstract][Full Text] [Related]
13. Patatin-like phospholipase domain-containing protein 3 rs738409-G in recipients of liver transplants is a risk factor for graft steatosis.
Finkenstedt A; Auer C; Glodny B; Posch U; Steitzer H; Lanzer G; Pratschke J; Biebl M; Steurer M; Graziadei I; Vogel W; Zoller H
Clin Gastroenterol Hepatol; 2013 Dec; 11(12):1667-72. PubMed ID: 23872669
[TBL] [Abstract][Full Text] [Related]
14. Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus.
Brandman D; Pingitore A; Lai JC; Roberts JP; Ferrell L; Bass NM; Terrault NA
Liver Transpl; 2011 Dec; 17(12):1380-6. PubMed ID: 21770018
[TBL] [Abstract][Full Text] [Related]
15. PNPLA3 as a liver steatosis risk factor following living-donor liver transplantation for hepatitis C.
Miyaaki H; Miuma S; Taura N; Shibata H; Soyama A; Hidaka M; Takatsuki M; Eguchi S; Nakao K
Hepatol Res; 2018 Feb; 48(3):E335-E339. PubMed ID: 28574625
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and risk factors for recurrence of nonalcoholic steatohepatitis following liver transplantation.
Tokodai K; Karadagi A; Kjaernet F; Romano A; Ericzon BG; Nowak G
Scand J Gastroenterol; 2019 Feb; 54(2):233-239. PubMed ID: 30999770
[TBL] [Abstract][Full Text] [Related]
17. High incidence of hepatocellular carcinoma and postoperative complications in patients with nonalcoholic steatohepatitis as a primary indication for deceased liver transplantation.
Kern B; Feurstein B; Fritz J; Fabritius C; Sucher R; Graziadei I; Bale R; Tilg H; Zoller H; Newsome P; Eschertzhuber S; Margreiter R; Öfner D; Schneeberger S
Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):205-210. PubMed ID: 30320609
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic steatohepatitis in donors for living donor liver transplantation.
Yamamoto K; Takada Y; Fujimoto Y; Haga H; Oike F; Kobayashi N; Tanaka K
Transplantation; 2007 Feb; 83(3):257-62. PubMed ID: 17297396
[TBL] [Abstract][Full Text] [Related]
19. Donor Diabetes and Steatosis Affects Recipient Survival Following Liver Transplantation Based on Etiology of Liver Cirrhosis.
Lim WH; Ng CH; Tan DJH; Xiao J; Fu CE; Ong C; Koh B; Chung C; Tan SN; Wong ZY; Mitchell K; Joseph AA; Tseng M; Syn N; Mak LY; Fung J; Huang DQ; Muthiah M; Tan EXX; Siddiqui MS
Transplantation; 2024 Feb; 108(2):473-482. PubMed ID: 37439778
[TBL] [Abstract][Full Text] [Related]
20. Combined Use of MR Fat Quantification and MR Elastography in Living Liver Donors: Can It Reduce the Need for Preoperative Liver Biopsy?
Yoon JH; Lee JM; Suh KS; Lee KW; Yi NJ; Lee KB; Han JK; Choi BI
Radiology; 2015 Aug; 276(2):453-64. PubMed ID: 25763828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
